Balumorexton (INN; likely developmental code name TAK-360) is a selective orexin OX2 receptor agonist which is under development for the treatment of narcolepsy and idiopathic hypersomnia.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.